Prostate Cancer
Predictors and trends of opioid-sparing radical prostatectomy from a large national cohort.
August 9, 2022
Satisfaction with Clinician-Led Germline Genetic Counseling in Patients with Prostate Cancer.
August 9, 2022
The role of multiparametric ultrasound in the detection of clinically significant prostate cancer.
August 9, 2022
A genome-wide CRISPR-Cas9 knockout screen identifies novel PARP inhibitor resistance genes in prostate cancer.
August 9, 2022
Active Surveillance for Intermediate-risk Prostate Cancer: A Systematic Review, Meta-analysis, and Metaregression
August 5, 2022
How Prostate Cancer Patients are Surveyed may Influence Self-Reported Sexual Function Responses.
August 5, 2022
Anxiety and Depression in Patients with Prostate Cancer, at Cancer Diagnosis and after a One-Year Follow-Up.
August 5, 2022
The STAT3 inhibitor GPB730 enhances the sensitivity to enzalutamide in prostate cancer cells.
August 4, 2022